OPKO Health, Inc. (OPK)

Market Cap	1.06B
Revenue (ttm)	716.37M
Net Income (ttm)	-243.10M
Shares Out	691.99M
EPS (ttm)	-0.33
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,606,143
Open	1.550
Previous Close	1.590
Day's Range	1.530 - 1.570
52-Week Range	0.850 - 1.750
Beta	1.64
Analysts	Strong Buy
Price Target	2.75 (+79.15%)
Earnings Date	Nov 4, 2024

About OPK

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Spain, Chile, Israel, Mexico, and internationally. The company’s Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare to physician offices, clinics, hospitals, employers,...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Nov 2, 1995
• Employees: 3,930
• Stock Exchange: NASDAQ
• Ticker Symbol: OPK
• Website: https://www.opko.com

Financial Performance

In 2023, OPKO Health's revenue was $863.50 million, a decrease of -14.01% compared to the previous year's $1.00 billion. Losses were -$188.86 million, -42.49% less than in 2022.

Analyst Forecast

According to 3 analysts, the average rating for OPK stock is "Strong Buy." The 12-month stock price forecast is $2.75, which is an increase of 79.15% from the latest price.

Price Target

$2.75

(79.15% upside)

Analyst Consensus: Strong Buy